Articles

Page 4 of 19

Content type: Poster presentation

Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen

Authors: F Aragão, I Vaz Pinto and J Vera

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P237

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV

Authors: ACA Deloof, H De Wolf, Y Verlinden, J Villacian and T Pattery

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P212

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

Authors: JV Fernández-Montero, L Martín-Carbonero, P Barreiro, NI Rallón, JM Benito, J González-Lahoz and V Soriano

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P206

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients

Authors: S Ferrara, A Tartaglia, T Santantonio and B Grisorio

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P204

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the 'real-life setting' proves the concept

Authors: P Ingiliz, MJ Obermeier, L Weitner, C Cordes, A Moll, B Hintsche, F Schlote, S Köppe, C Mayr and A Baumgarten

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P202

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

PK/PD modeling supports the dose-escalation decision in VIKING

Authors: M Lovern, M Underwood, G Nichols and I Song

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P182

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers

Authors: AGA Jackson, A Hill, LJ Else, DJ Back, R Morley, R Puls, J Amin, E Lin and M Boffito

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P180

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients

Authors: M Siccardi, A D'Avolio, L Baietto, M Simiele, S Bonora, DJ Back, G Di Perri and A Owen

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P178

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children

Authors: PK Gitta, L Kendall, V Musiime, K Adkison, AA Kekitiinwa, A Ferrier, O Opilo, Y Lou, MF Bwakura-Dangarembi, P Nahirya-Ntege, S Bakeera-Kitaka, M Ssenyonga, W Snowden, D Burger, AS Walker and D Gibb

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P176

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

The impact of late presentation: analysis of a cohort of 313 Portuguese patients

Authors: D Alfaiate, AC Miranda, J Rijo, D Fernandes, F Borges, H Farinha and K Mansinho

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P174

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia

Authors: M Bloch, J Hoy, N Cunningham, N Roth, N Andrianopoulos, C Rayner and A Carr

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P172

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Audit of telephone HIV clinics: effective and acceptable

Authors: WFC Woolley, C Babu, A Sukthankar and O McQuillan

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P170

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Offering HIV testing in an emergency admission unit in Newcastle upon Tyne, UK — a pilot audit study

Authors: S Ellis, L Graham, DA Price and ELC Ong

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P168

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

BEST: Better Equipped to Start Treatment

Authors: J Bennett

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P166

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Pro-viral DNA and antiretroviral treatment simplification

Authors: D Zucman, C Rouzioux and V Avettand-Fenoel

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P143

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)

Authors: L Pérez, J Aleman, C Correa, J Pérez, C Fonseca, C Aragones, D Pérez, A Alvarez, AM Vandamme, V Kourí and K Van Laethem

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P141

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy

Authors: JE Gaytán-Martínez, JA Mata-Marín, F Gutierrez-Escolano, L Pérez-Saleme, S Treviño-Pérez, JG Vázquez-Rosales, N Matías-Juan, RD Díaz-Ramos and R Arias-Flores

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P139

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Abstract withdrawn

Authors:

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P137

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil

Authors: N Mantovani Pena, R Gonçalves Azevedo, D Funayama Castro, R Sobhie Diaz and S Vasconcelos Komninakis

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P135

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy

Authors: AG Marcelin, C Charpentier, M Wirden, D Descamps and V Calvez

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P133

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs

Authors: F Pulido, JR Arribas, A Hill, Y van Delft and C Moecklinghoff

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P131

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Clinical application of genotypic co-receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort

Authors: MJ Obermeier, A Carganico, S Dupke, D Schranz, C Cordes, M Freiwald, G Klausen, S Köppe, C Schuler, C Mayr, D Schleehauf, T Berg, I Krznaric and A Baumgarten

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P129

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Detection of HIV type 1 mutations on the pol region in untreated patients in Northern Vietnam: determination of drug resistance and subtypes

Authors: S Ranger-Rogez, M Al Jawhari, B Nguyen, N Pham Hong, T Tran Quoc, J Pascual, J Doll, M Harzic, G Viretto and P Weinbreck

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P127

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Behaviour and attitudes in HIV (BEAHIV): a national survey study to examine the level of agreement between physicians and patients in symptom reporting

Authors: A Rachlis, J Gill, M Harris, J Macleod, C Worthington, J Brunetta, A Tsang, H Hew, J Leith, F Camacho, D Turner and C Fraser

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P106

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort

Authors: M Cervero, C García Lacalle, JL Agud, R Torres Perea, E García-Benaya, J Jusdado, C Pérez Pons and M del Álamo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P104

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

The serum level of 25-OH vitamin D and Th1 cytokine pattern in HIV infection versus hepatitis C virus infection and hepatitis B virus infection

Authors: SA Iacob, D Banica, E Panaitescu, M Cojocaru and D Iacob

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P102

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Rates of bone fractures in a cohort of HIV-infected adults in the UK

Authors: A Samarawickrama, R Malik, M Fisher, Y Gilleece and K Walker-Bone

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P100

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA

Authors: L Ryom, A Mocroft, P Reiss, B Ledergerber, S De Wit, D Duiculescu, AD Monforte, M Murphy, JD Lundgren and O Kirk

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P82

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study

Authors: G Moyle, C Orkin, M Fisher, J Anderson, J Dhar, MH Wang and J Ewan

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P80

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Altered phosphate metabolism in HIV-1-infected patients: another feature of metabolic syndrome?

Authors: P Grima, A Zizza, M Guido, P Calabrese, R Chiavaroli, MR Sodo, M Tana and P Tundo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P78

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Nutritional status in HIV-infected patients using Changi's mini nutritional assessment

Authors: M Cervero, V Alcázar, R Sanz, C García-La Calle and JL Agud

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P76

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Mesenteric fat thickness in a group of HIV patients on HAART

Authors: SS Lee, E Liu and KW To

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P72

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Switching to dual therapy with darunavir/ritonavir and etravirine: a simplification strategy

Authors: M Tyrer, L Swaden, NJ Marshall and M Johnson

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P51

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome

Authors: T Baudry, A Boibieux, MC Gagnieu, L Cotte, JM Livrozet, P Miahles, D Makhloufi, C Chidiac, D Peyramond and T Ferry

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P47

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)

Authors: K Arastéh, A Ward, A Plettenberg, JM Livrozet, C Cordes, A Winston, E Wang and A Quinson

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P45

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Oral presentation

What affects the bone in our HIV-positive patients?

Authors: CA Fux

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O41

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study

Authors: J Ghosn, A Chermak, A Houssaini, G Peytavin, S Lambert-Niclot, N Eychenne, L Slama, A Brunet, C Duvivier, A Simon, AG Marcelin, P Flandre and C Katlama

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P41

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Immunologic impact of maraviroc in clinical practice of a university hospital

Authors: S Plata Paniagua, N Trovato Lopez, I Castillo Romera, A Ais Larisgoitia, J Bellon Cano and M Sanjurjo Saez

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P39

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008

Authors: M Bruyand, S Geffard, S Lawson-Ayayi, F Dauchy, G Miremont-Salamé, C Greib, S Farbos, P Morlat and F Dabis

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P37

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Oral presentation

HIV/HAART and the brain — what's going on?

Authors: P Portegies

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O35

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice

Authors: JM Llibre, E Martínez, P Barreiro, R Escrig, E Ribera, M Cervantes, A Imaz, F Gutierrez, H Knobel, A Ornelas, FX Zamora and B Clotet

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P35

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Oral presentation

0315. The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers

Authors: J Ashby, LJ Garvey, OW Erlwein, H Lamba, R Weston, K Legg, MO McClure, L Dickinson, A D'Avolio, DJ Back and A Winston

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O33

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Oral presentation

0313. Hepatitis C — feedback from the Consensus Conference on the Management of Acute Hepatitis C (AHC) in Paris, May 2010

Authors: M Vogel

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O31

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Oral presentation

0311. Hepatitis C new drugs

Authors: H Wedemeyer

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O29

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Oral presentation

0233. Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC

Authors: MT May, M Gompels and CA Sabin

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O27

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort

Authors: J van Lunzen, G Fätkenheuer, T Lutz, S Klauke, S Mauss, H Knechten, P Braun, L Gallo and J Goldbach

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P12

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral treatment amongst an adult treatment cohort from South Africa

Authors: P Bock, G Fatti and A Grimwood

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P10

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)

Authors: RW Baran, B Dietz, LM Fredrick, M Tian and T Podsadecki

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P8

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)

Authors: A Lazzarin, M Johnson, E Ribera, L Weitner, SS Chen and DR Warren

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P6

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Content type: Poster presentation

Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data

Authors: E DeJesus, A Mills, L Bhatti, C Conner and S Storfer

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P4

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF

Articles

Journal of the International AIDS Society